FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jennifer Robinson

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

United States

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Jennifer G Robinson
Management of familial hypercholesterolemia: a review of the recommendations from the national lipid association expert panel on familial hypercholesterolemia.
Mark A Espeland; Joseph S Goveas; Patricia E Hogan; Simin Liu; Kamal Masaki; Susan M Resnick; Jennifer G Robinson; Rebecca Rossom; Mustafa S Siddiqui; Kristine Yaffe; R Nick Bryan; Ramon Casanova; Laura H Coker
Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies.
Jennifer G Robinson
What is the role of advanced lipoprotein analysis in practice?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jennifer Robinson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer G Robinson
Management of familial hypercholesterolemia: a review of the recommendations from the national lipid association expert panel on familial hypercholesterolemia.
Journal of managed care pharmacy : JMCP 2013;19(2):139-49.
2013: Mark A Espeland; Joseph S Goveas; Patricia E Hogan; Simin Liu; Kamal Masaki; Susan M Resnick; Jennifer G Robinson; Rebecca Rossom; Mustafa S Siddiqui; Kristine Yaffe; R Nick Bryan; Ramon Casanova; Laura H Coker
Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies.
Diabetes care 2013;36(1):90-7.
2012: Jennifer G Robinson
What is the role of advanced lipoprotein analysis in practice?
Journal of the American College of Cardiology 2012;60(25):2607-15.
2012: Jennifer G Robinson; Songfeng Wang; Terry A Jacobson
Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.
The American journal of cardiology 2012;110(10):1468-76.
2012: Jennifer G Robinson; Elizabeth Lawler; Catherine Rahilly-Tierney; J Michael Gaziano
Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men.
Journal of clinical lipidology 2012;6(1):58-65.
2011: Jennifer G Robinson; Jeffrey Rosen; Arvind Shah; Christie M Ballantyne; Mary E Hanson; Willa Hsueh; Jianxin Lin; Robert S Lowe; Andrew M Tershakovec
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Journal of clinical lipidology 2011;5(6):474-82.
2011: Jennifer G Robinson; Anne C Goldberg
Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Journal of clinical lipidology 2011;5(3 Suppl):S18-29.
2011: Nkechinyere Ijioma; Jennifer G Robinson
Lipid-lowering effects of ezetimibe and simvastatin in combination.
Expert review of cardiovascular therapy 2011;9(2):131-45.
2010: Jennifer G Robinson; Benjamin Booth
Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006.
Journal of clinical lipidology 2010;4(6):483-90.
2010: Jennifer G Robinson
Low high-density lipoprotein cholesterol and chronic disease risk marker or causal?
Journal of the American College of Cardiology 2010;55(25):2855-7.
2010: Jennifer G Robinson
Dalcetrapib: a review of Phase II data.
Expert opinion on investigational drugs 2010;19(6):795-805.
2010: Judith Hsia; Rebecca J Rodabough; JoAnn E Manson; Simin Liu; Matthew S Freiberg; William Graettinger; Milagros C Rosal; Barb Cochrane; Donald Lloyd-Jones; Jennifer G Robinson; Barbara V Howard
Evaluation of the American Heart Association cardiovascular disease prevention guideline for women.
Circulation. Cardiovascular quality and outcomes 2010;3(2):128-34.
2010: Jennifer G Robinson; Robert Wallace; Monika Maria Safford; Mary Pettinger; Barbara Cochrane; Marcia G Ko; Mary J O'Sullivan; Kamal Masaki; Helen Petrovich
Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative.
Journal of clinical lipidology 2010;4(1):36-45.
2010: Janet A Tooze; Sarah A Gaussoin; Susan M Resnick; Nancy J Fischbein; Jennifer G Robinson; R Nick Bryan; Yang An; Mark A Espeland
A uniform approach to modeling risk factor relationships for ischemic lesion prevalence and extent: the Women's Health Initiative Magnetic Resonance Imaging study.
Neuroepidemiology 2010;34(1):55-62.
2009: Jennifer G Robinson; Christie M Ballantyne; Scott M Grundy; Willa A Hsueh; Hans-Henrik Parving; Jeffrey B Rosen; Adeniyi J Adewale; Adam B Polis; Joanne E Tomassini; Andrew M Tershakovec
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
The American journal of cardiology 2009;103(12):1694-702.
2009: Jennifer G Robinson; Songfeng Wang; Brian J Smith; Terry A Jacobson
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
Journal of the American College of Cardiology 2009;53(4):316-22.
2009: Jennifer G Robinson
Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges.
Drugs & aging 2009;26(11):917-31.
2009: Jennifer G Robinson; Kathleen M Fox; Michael F Bullano; Susan Grandy
Atherosclerosis profile and incidence of cardiovascular events: a population-based survey.
BMC cardiovascular disorders 2009;9():46.
2009: Jennifer G Robinson; Kathleen M Fox; Susan Grandy
Attitudes about health and health-related behaviors in patients with cardiovascular disease or at elevated risk for cardiovascular disease.
Preventive cardiology 2009;12(3):136-43.
2009: Jennifer G Robinson
Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin.
Vascular health and risk management 2009;5(1):31-43.
2008: Jennifer G Robinson; Robert Wallace; Marian C Limacher; Hong Ren; Barbara B Cochrane; Sylvia Wassertheil-Smoller; Judith K Ockene; Patricia L Blanchette; Marcia G Ko
Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
The American journal of cardiology 2008;102(6):693-9.
2008: Judith Hsia; James D Otvos; Jacques E Rossouw; LieLing Wu; Sylvia Wassertheil-Smoller; Susan Hendrix; Jennifer G Robinson; Bernedine Lund; Lewis H Kuller
Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(9):1666-71.
2008: Jennifer G Robinson
Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
The American journal of cardiology 2008;101(7):1009-15.
2008: Jennifer G Robinson
Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
PPAR research 2008;2008():891425.
2007: Jennifer G Robinson
Simvastatin: present and future perspectives.
Expert opinion on pharmacotherapy 2007;8(13):2159-27.
2007: Sarah A Jaramillo; Deborah Felton; Leeann Andrews; Lisa Desiderio; Rose K Hallarn; Sharon D Jackson; Laura H Coker; Jennifer G Robinson; Judith K Ockene; Mark A Espeland
Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI).
Academic radiology 2007;14(5):603-12.
2007: Jennifer G Robinson; Helmut Schrott
Statin pleiotropy: a popular concept but clinical significance unclear.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(2):81-3.
2007: Jennifer G Robinson; George L Bakris; James C Torner; Neil J Stone; Robert Wallace
Is it time for a cardiovascular primary prevention trial in the elderly?
Stroke; a journal of cerebral circulation 2007;38(2):441-50.
2007: Charles Kooperberg; Mary Cushman; Judith Hsia; Jennifer G Robinson; Aaron Aragaki; John K Lynch; Alison E Baird; Karen C Johnson; Lewis H Kuller; Shirley A A Beresford; Beatriz L Rodriguez
Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials.
PLoS clinical trials 2007;2(6):e28.
2007: Jennifer G Robinson
Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.
Current atherosclerosis reports 2007;9(1):64-71.
2006: Jennifer G Robinson; Robert Wallace; Marian C Limacher; Alicia Sato; Barbara B Cochrane; Sylvia Wassertheil-Smoller; Judith K Ockene; Patricia L Blanchette; Marcia G Ko
Elderly women diagnosed with nonspecific chest pain may be at increased cardiovascular risk.
Journal of women's health (2002) 2006;15(10):1151-60.
2006: Jennifer G Robinson; Neil J Stone
Identifying patients for aggressive cholesterol lowering: the risk curve concept.
The American journal of cardiology 2006;98(10):1405-8.
2006: Jennifer G Robinson; Neil J Stone
Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.
The American journal of cardiology 2006;98(4A):39i-49i.
2006: Jennifer G Robinson; Michael H Davidson
How low to target LDL?
Nature clinical practice. Endocrinology & metabolism 2006;2(8):414-5.
2006: Jennifer G Robinson; Michael H Davidson
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Expert review of cardiovascular therapy 2006;4(4):461-76.
2006: John R Crouse; Marshall B Elam; Jennifer G Robinson; Walter T Ambrosius; Henry N Ginsberg
Cholesterol management: targeting a lower low-density lipoprotein cholesterol concentration increases adult treatment panel-III goal attainment.
The American journal of cardiology 2006;97(11):1667-9.
2006: Judith Hsia; JoAnn E Manson; Lewis Kuller; Mary Pettinger; John H Choe; Robert D Langer; Marian C Limacher; Albert Oberman; Judith K Ockene; Mary J O'Sullivan; Jennifer G Robinson
Impact of cyclooxygenase inhibitors in the Women's Health Initiative hormone trials: secondary analysis of a randomized trial.
PLoS clinical trials 2006;1(5):e26.
2005: Jennifer G Robinson; Brian Smith; Nidhi Maheshwari; Helmut Schrott
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
Journal of the American College of Cardiology 2005;46(10):1855-62.
2005: Jennifer G Robinson; Nidhi Maheshwari
A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years.
The American journal of cardiology 2005;95(3):373-8.
2004: Neal D Kohatsu; Jennifer G Robinson; James C Torner
Evidence-based public health: an evolving concept.
American journal of preventive medicine 2004;27(5):417-21.